How do you manage HR+HER2 negative ILC metastatic recurrence in a post-menopausal woman with extensive GI involvement complicated by a small bowel obstruction?

I think the answer to this question depends on a few factors. The management and outcome of patients with malignant bowel obstruction is described quite well by Tuca et al., PMID 22904637. The type of therapy I try would be influenced by their overall condition. Certainly, I would consider this an "...